Ibuprofen, ketoprofen and fixed-dose combinations of the two drugs can seriously exacerbate infections, a committee of the European Medicines Agency has warned.
EMA’s Pharmacovigilance Risk Assessment Committee has concluded that based on the available data, the risk of complications due to masking of symptoms of infection associated with the use of
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?